Improving physicians’ knowledge of the costs of common medications and willingness to consider costs when prescribing

Korn, Lisa M.; Reichert, Steven; Simon, Todd; Halm, Ethan A.

doi:10.1046/j.1525-1497.2003.20115.x

Cited by 71 publications

(39 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Given the demonstration by Korn and co-workers 16 of the benefits of improving the awareness of practitioners of the impact of patient expenses on prescribing patterns in a medical context, we trust that the cost-per-wear analysis reported here will be of similar benefit to contact lens practitioners and lens wearers.…”

supporting

confidence: 53%

A ‘cost‐per‐wear’ model based on contact lens replacement frequency

Efron

Efron²,

Morgan

et al. 2010

Clinical and Experimental Optometry

View full text Add to dashboard Cite

Purpose:The aim was to construct and advise on the use of a cost-per-wear model based on contact lens replacement frequency, to form an equitable basis for cost comparison. Methods: The annual cost of professional fees, contact lenses and solutions when wearing daily, two-weekly and monthly replacement contact lenses is determined in the context of the Australian market for spherical, toric and multifocal prescription types. This annual cost is divided by the number of times lenses are worn per year, resulting in a 'cost-per-wear'. The model is presented graphically as the cost-per-wear versus the number of times lenses are worn each week for daily replacement and reusable (twoweekly and monthly replacement) lenses. Results: The cost-per-wear for two-weekly and monthly replacement spherical lenses is almost identical but decreases with increasing frequency of wear. The cost-per-wear of daily replacement spherical lenses is lower than for reusable spherical lenses, when worn from one to four days per week but higher when worn six or seven days per week. The point at which the cost-per-wear is virtually the same for all three spherical lens replacement frequencies (approximately AUD$3.00) is five days of lens wear per week. A similar but upwardly displaced (higher cost) pattern is observed for toric lenses, with the cross-over point occurring between three and four days of wear per week (AUD$4.80). Multifocal lenses have the highest price, with cross-over points for daily versus two-weekly replacement lenses at between four and five days of wear per week (AUD$5.00) and for daily versus monthly replacement lenses at three days per week (AUD$5.50). Conclusions: This cost-per-wear model can be used to assist practitioners and patients in making an informed decision in relation to the cost of contact lens wear as one of many considerations that must be taken into account when deciding on the most suitable lens replacement modality.

show abstract

supporting

confidence: 53%

A ‘cost‐per‐wear’ model based on contact lens replacement frequency

Efron

Efron²,

Morgan

et al. 2010

Clinical and Experimental Optometry

View full text Add to dashboard Cite

show abstract

“…There was no statistical significance in the implementation rate per class year (P = .26). including 9 teaching methods (eg, lectures, seminars, small group, role play, and workshops [19][20][21]; simulated case scenario [22]; morbidity or clinicopathologic conferences; grand rounds; orientation on community resources; video examples of role play [23]; review of resident "sign out"; hospital quality assurance programs or committees; and teamwork curriculum, exercises, and training [24,25]) and 12 evaluation methods (eg, cognitive testing [26], self-reflection and self-reporting, self-directed chart audit or postclinic or postdischarge analysis [27], portfolio documentation [28], surveys of residents [29], resident exit interview(s), low-and high-fidelity simulations [30], evaluation of case-based presentations, direct observation [30], simulations including teamwork exercises [25], standardized patients [23,31], and 360°global evaluation from system participants [32]). …”

Section: Discussionmentioning

confidence: 99%

A retrospective review of required projects in systems-based practice in a single anesthesiology residency: a 10-year experience

Sakai

Emerick

Patel

2015

Journal of Clinical Anesthesia

View full text Add to dashboard Cite

“…If we acknowledge that physicians make choices which impact on how the total health-care resources are allocated between tasks and patients, and as such should be expected to choose cost effective treatments, they must be given the proper information and decision support tools. We see from other studies that physicians do not have good access to cost information, and often they believe that they could prescribe more cost effectively if they had access to better information [11,30,31]. In a recent study, Feldman, Shihab et al concluded that displaying the prices of diagnostic tests can influence physicians ordering behaviour and lead to a reduction in costs [32].…”

Section: Discussionmentioning

confidence: 99%

Norwegian Physicians’ Knowledge of the Prices of Pharmaceuticals: A Survey

2013

View full text Add to dashboard Cite

The objectives of this study are to measure physicians’ knowledge of the prices of pharmaceuticals, and investigate whether there are differences in knowledge of prices between groups of physicians. This article reports on a survey study of physicians’ knowledge of the prices of pharmaceuticals conducted on a representative sample of Norwegian physicians in the autumn of 2010. The importance of physicians’ knowledge of costs derives from their influence on total spending and allocation of limited health-care resources. Physicians are important drivers in the effort to contain costs in health care, but only if they have the knowledge needed to choose the most cost-effective treatment options. A survey was sent to 1 543 Norwegian physicians, asking them for price estimates and their opinions on the importance of considering the cost of treatment to society as a decision factor when treating their patients. This article deals with a subsection in which the physicians were asked to estimate the price of five pharmaceuticals: simvastatin, alendronate (Fosamax), infliximab (Remicade), natalizumab (Tysabri) and escitalopram (Cipralex). The response rate was 65%. For all the five pharmaceuticals, more than 50% and as many as 83% gave responses that differed more than 50% from the actual drug price. The price of more expensive pharmaceuticals was underestimated, while the opposite was the case for less expensive medicines. The data show that physicians in general have poor knowledge of the prices of the pharmaceuticals they offer their patients. However, the physicians who frequently deal with a drug have better knowledge of its price than those who do not handle a medication as often. The data also suggest that those physicians who agree that cost of care to society is an important decision factor have better knowledge of drug prices.

show abstract

Improving physicians’ knowledge of the costs of common medications and willingness to consider costs when prescribing

Cited by 71 publications

References 20 publications

A ‘cost‐per‐wear’ model based on contact lens replacement frequency

A ‘cost‐per‐wear’ model based on contact lens replacement frequency

A retrospective review of required projects in systems-based practice in a single anesthesiology residency: a 10-year experience

Norwegian Physicians’ Knowledge of the Prices of Pharmaceuticals: A Survey

Contact Info

Product

Resources

About